Treatment options for small intestinal bacterial overgrowth

Digestive and Liver Disease Supplements

Volumn 3, Issue 2, 2009, Pages 50-53

  Gabrielli, M ^a   Sparano, L ^a   Roccarina, D ^a   Vitale, G ^a   Lauritano, E C ^a   Gasbarrini, A ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Bacterial overgrowth; Intestinal flora; Small bowel; Treatment

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CHLORTETRACYCLINE; CIPROFLOXACIN; METRONIDAZOLE; NEOMYCIN; NORFLOXACIN; PLACEBO; PROBIOTIC AGENT; RIFAXIMIN; TETRACYCLINE;

ABSENCE OF SIDE EFFECTS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL OVERGROWTH; CONSTIPATION; DIARRHEA; DISEASE PREDISPOSITION; DIZZINESS; DRUG CHOICE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; HUMAN; INTESTINE FLORA; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS FERMENTUM; LACTOBACILLUS PLANTARUM; PRIORITY JOURNAL; RASH; SACCHAROMYCES BOULARDII; SMALL INTESTINE; TREATMENT DURATION; WEAKNESS;

EID: 67650388570     PISSN: 15945804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1594-5804(09)60020-6     Document Type: Article

References (24)

1. Gasbarrini A., Lauritano E.C., Gabrielli M., et al. Small intestinal bacterial overgrowth: diagnosis and treatment. Dig Dis 25 (2007) 237-240
2. Donaldson Jr. R.M. Normal bacterial population of the intestine and their relation to intestinal function. N Engl J Med 270 (1964) 938-945
3. Husebye E. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy 51 Suppl 1 (2005) 1-22
4. De Ponti F., and Tonini M. Irritable bowel syndrome: new agents targeting serotonin receptor subtypes. Drugs 61 (2001) 317-332
5. Lauritano E.C., Gabrielli M., Scarpellini E., et al. Small intestinal bacterial overgrowth recurrence after antibiotic therapy. Am J Gastroenterol 103 (2008) 2031-2035
6. Mancilla A.C., Madrid S., Hurtado H.C., et al. Small intestine bacterial overgrowth in patients with chronic pancreatitis. Rev Med Chile 136 (2008) 976-980
7. Tursi A., Brandimarte G., and Giorgetti G.M. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol 98 (2003) 839-843
8. Tursi A. Gastrointestinal motility disturbances in celiac disease. J Clin Gastroenterol 38 (2004) 642-645
9. Corazza G.R., Di Stefano M., and Scarpignato C. Treatment of functional bowel disorders: is there room for antibiotics?. Digestion 73 Suppl 1 (2006) 38-46
10. Di Stefano M., and Corazza G.R. Treatment of small intestine bacterial overgrowth and related symptoms by rifaximin. Chemotherapy 51 Suppl 1 (2005) 103-109
11. Quigley E.M., and Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology 130 Suppl 1 (2006) 78-90
12. Di Stefano M., Malservisi S., Veneto G., et al. Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther 14 (2000) 551-556
13. Di Stefano M., Miceli E., Missanelli A., et al. Absorbable vs. non absorbable antibiotics in the treatment of small intestine bacterial overgrowth in patients with blind-loop syndrome. Aliment Pharmacol Ther 21 (2005) 985-992
14. Attar A., Flourié B., Rambaud J.C., et al. Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology 117 (1999) 794-797
15. Castiglione F., Rispo A., Di Girolamo E., et al. Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease. Aliment Pharmacol Ther 18 (2003) 1107-1112
16. Pimentel M., Chow E.J., and Lin H.C. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 98 (2003) 412-419
17. Lauritano E.C., Gabrielli M., Lupascu A., et al. Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther 22 (2005) 31-35
18. Cuoco L., and Salvagnini M. Small intestinal bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin. Minerva Gastroenterol Dietol 52 (2006) 89-95
19. Scarpellini E., Gabrielli M., Lauritano E.C., et al. High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther 25 (2007) 781-786
20. Lauritano EC, Gabrielli M, Scarpellini E, et al. Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole. Eur Rev Med Pharmacol Sci 2009, in press.
21. Stotzer P.O., Blomberg L., Conway P.L., et al. Probiotic treatment of small intestinal bacterial overgrowth by Lactobacillus fermentum KLD. Scand J Infect Dis 28 (1996) 615-619
22. Young R.J., and Vanderhoof J.A. Probiotic therapy in children with short bowel syndrome and bacterial overgrowth. Gastroenterology 112 (1997) A916
23. Gaon D., Garmendia C., Murrielo N.O., et al. Effect of Lactobacillus strains (L. casei and L. Acidophillus Strains cerela) on bacterial overgrowth-related chronic diarrhea. Medicina (B Aires) 62 (2002) 159-163
24. Gabrielli M, Lauritano EC, Scarpellini E, et al. Bacillus clausii as a treatment of small intestinal bacterial overgrowth. Am J Gastroenterol 2009, in press.